Application Provides Discovery, Collaboration, and Business Intelligence Tools

This "business DNA” can then be utilized to increase search/match relevancy and materially enhance success rates and lower costs.

E-Zassi's proprietary Deep DNA (Device Network Attributes) profiling technology captures in-depth and highly relevant search criteria on the proficiencies, preferences, and targeted areas for development of individuals and organizations. The company believes that allowing members to leverage these vital attributes to enable collaboration in the medical device sector will lower costs and create efficiencies; as these capabilities are not typically identified or utilized by existing broad, conventional business networks or search engines.

Available by subscription, e-Zassi members will have 24/7 access to a variety of modules including the world's first Innovation Assessment software platform. This platform allows members to deeply analyze and profile medical technologies via a simple to use question and answer process. Remarkably, the program utilizes no confidential information to generate powerful development and commercially related outputs that are critical to activities such as: technology transfer; business development; market and commercial analysis; due diligence; intellectual property and patent development; and product development and financial planning.

The company recognizes the value provided by the ability to gain insights earlier in the innovation, development, and financing decision process of a new product or technology. Knowledge in areas such as its clinical, regulatory, reimbursement, market, manufacturing, distribution, and sales requirements are critical in helping to ensure successful development and commercialization. The e-Zassi system provides this decision support knowledge in minutes providing great value to innovators, device manufacturers, service providers, venture capital firms, researchers and healthcare providers as they diligence, develop, fund, or provide services for medical technologies.

"The [US]$250 billion global medical device industry invests more than $40 billion annually in new product innovation and development alone. As such, it requires rapid decision-making, comprehensive planning, and increased efficiency in terms of technology due diligence, business networking, and strategic partnering. As veterans from the medical device space ourselves, we know traditional connectivity methods such as conventions, magazine advertising, and even the use of broad, non-medical device online networking sites are not really cost-effective and do not address the very specific technical and business requirements of our industry. We knew it was time to combine the latest in Cloud Computing technology with our powerful new DNA-based assessment and collaboration software platforms to create a vertical search engine dedicated to our specific device industry as existing general search engines are becoming flooded with too much noise,” stated Peter M. von Dyck, e-Zassi's founder and chief executive officer.

Related Links:
Zassi Medical Evolutions